Literature DB >> 15274752

Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters.

Vesna Bacić Vrca1, Franjo Skreb, Ivana Cepelak, Ljiljana Mayer.   

Abstract

In this study, the effect of supplementation with a fixed combination of antioxidants (vitamins C and E, beta-carotene and selenium) on concentrations of antioxidative parameters in serum was monitored. Measurements were performed prior to the commencement of therapy and after 30 and 60 days in patients with Graves' disease treated with methimazole. Patients who received extra supplementation with antioxidants (group A, n = 29) attained euthyroidism faster than the patients treated only with methimazole (group B, n = 28). Statistically significant differences were achieved after supplementation with antioxidants for all investigated parameters (uric acid, transferrin, ferritin), except TAS and glucose. Nevertheless, due to the fact that all measured parameters remained within the range of referent values, they may not be proposed as reliable indicators of the level of oxidative stress in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274752

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  4 in total

Review 1.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 2.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

3.  A case-control study of selenoprotein genes polymorphisms and autoimmune thyroid diseases in a Chinese population.

Authors:  Ling Xiao; Jianghong Yuan; Qiuming Yao; Ni Yan; Ronghua Song; Wenjuan Jiang; Danfeng Li; Liangfeng Shi; Jin-An Zhang
Journal:  BMC Med Genet       Date:  2017-05-12       Impact factor: 2.103

4.  Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.

Authors:  Torquil Watt; Per Cramon; Jakob Bue Bjorner; Steen Joop Bonnema; Ulla Feldt-Rasmussen; Christian Gluud; Jeppe Gram; Jane Lindschou Hansen; Laszlo Hegedüs; Nils Knudsen; Pernille Bach-Mortensen; Runa Nolsøe; Birte Nygaard; Flemming Pociot; Maria Skoog; Per Winkel; Ase Krogh Rasmussen
Journal:  Trials       Date:  2013-04-30       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.